rs138803905
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052859.4(RFT1):c.1270C>T(p.Arg424Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,612,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_052859.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RFT1 | NM_052859.4 | c.1270C>T | p.Arg424Cys | missense_variant | 12/13 | ENST00000296292.8 | NP_443091.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFT1 | ENST00000296292.8 | c.1270C>T | p.Arg424Cys | missense_variant | 12/13 | 1 | NM_052859.4 | ENSP00000296292.3 | ||
ENSG00000272305 | ENST00000607283.5 | n.133C>T | non_coding_transcript_exon_variant | 2/5 | 5 | ENSP00000475819.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152114Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000364 AC: 9AN: 247068Hom.: 0 AF XY: 0.0000450 AC XY: 6AN XY: 133270
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1460412Hom.: 0 Cov.: 32 AF XY: 0.0000358 AC XY: 26AN XY: 726270
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74434
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2023 | The c.1270C>T (p.R424C) alteration is located in exon 12 (coding exon 12) of the RFT1 gene. This alteration results from a C to T substitution at nucleotide position 1270, causing the arginine (R) at amino acid position 424 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
RFT1-congenital disorder of glycosylation Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 04, 2022 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 424 of the RFT1 protein (p.Arg424Cys). This variant is present in population databases (rs138803905, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with RFT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 469624). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at